CIBC Private Wealth Group
CLPT icon

CIBC Private Wealth Group’s ClearPoint Neuro CLPT Stock Holding History

CIBC Private Wealth Group’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$14 Hold
1
– – ﹤0.01% 3378
2025
Q3 		$22 Buy
+1
New +$12 ﹤0.01% 3042
2024
Q3 		– Sell
-927
Closed -$5.22K – 3143
2024
Q2 		$5.22K Hold
927
– – ﹤0.01% 2502
2024
Q1 		$6.24K Buy
+927
New +$6.48K ﹤0.01% 2441

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
FCM
FirstWave Capital Management Miami, Florida $94.1M AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CIBC Private Wealth Group's CLPT Position: Q4 2025 in Review

CIBC Private Wealth Group held its ClearPoint Neuro (CLPT) position steady in Q4 2025 at 1 share worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3378.

CIBC Private Wealth Group first reported a position in CLPT in Q1 2024 and has held it in 4 quarters since. The position peaked at $6.24K in Q1 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q4 2025.

  • CIBC Private Wealth Group held 1 share of ClearPoint Neuro worth $14 as of Q4 2025.
  • CIBC Private Wealth Group left its ClearPoint Neuro share count unchanged in Q4 2025.
  • ClearPoint Neuro made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3378 holding.
  • CIBC Private Wealth Group first reported a position in ClearPoint Neuro in Q1 2024 and has held it in 4 quarters since.
  • CIBC Private Wealth Group's ClearPoint Neuro position peaked at $6.24K in Q1 2024.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.